Last reviewed · How we verify
Capecitabine and aflibercept
Capecitabine and aflibercept is a Small molecule drug developed by John Strickler, M.D.. It is currently in Phase 1 development.
At a glance
| Generic name | Capecitabine and aflibercept |
|---|---|
| Sponsor | John Strickler, M.D. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer (PHASE2)
- Predictive Value of Drug Sensitivity Testing Tumorspheres From Patients With Metastatic Colorectal Cancer (PHASE2)
- Anticancer Vigilance Of Cardiac Events (AVOCETTE) in Metastatic Colorectal Cancer
- Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer (PHASE1, PHASE2)
- Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers (PHASE1)
- A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer (PHASE2)
- Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient (PHASE1, PHASE2)
- Capecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Capecitabine and aflibercept CI brief — competitive landscape report
- Capecitabine and aflibercept updates RSS · CI watch RSS
- John Strickler, M.D. portfolio CI
Frequently asked questions about Capecitabine and aflibercept
What is Capecitabine and aflibercept?
Capecitabine and aflibercept is a Small molecule drug developed by John Strickler, M.D..
Who makes Capecitabine and aflibercept?
Capecitabine and aflibercept is developed by John Strickler, M.D. (see full John Strickler, M.D. pipeline at /company/john-strickler-m-d).
What development phase is Capecitabine and aflibercept in?
Capecitabine and aflibercept is in Phase 1.
Related
- Manufacturer: John Strickler, M.D. — full pipeline
- Compare: Capecitabine and aflibercept vs similar drugs
- Pricing: Capecitabine and aflibercept cost, discount & access